Seyitler Kimyanayi AS (IST:SEYKM) Research & Development: ₺0.7 Mil (TTM As of Mar. 2026)


IST:SEYKM Seyitler Kimya Sanayi AS IST:SEYKM
64 GF Score
Price ₺4.63
GF Value ₺2.82
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Seyitler Kimyanayi AS Research & Development?

Seyitler Kimyanayi AS IST:SEYKM -2.11% 64 Research & Development is ₺0.7 Mil as of Mar. 2026. GuruFocus rates IST:SEYKM with a GF Score™ of 64/100 and a GF Value™ of ₺2.82 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Seyitler Kimyanayi AS's Research & Development for the three months ended in Mar. 2026 was ₺0.7 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₺0.7 Mil.

Seyitler Kimyanayi AS  (IST:SEYKM) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Seyitler Kimyanayi AS Research & Development Related Terms

Seyitler Kimyanayi AS Research & Development Historical Data

* Premium members only.

The historical data trend for Seyitler Kimyanayi AS's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Seyitler Kimyanayi AS Research & Development Chart

Seyitler Kimyanayi AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Seyitler Kimyanayi AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.72
IST:SEYKM
64GF Score
Seyitler Kimya Sanayi AS IST:SEYKM
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Seyitler Kimyanayi AS Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺0.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₺0.7 Mil mean?
Seyitler Kimyanayi AS (IST:SEYKM) has a Research & Development of ₺0.7 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Seyitler Kimyanayi AS and its competitors.
Is Seyitler Kimyanayi AS's Research & Development too high?
Seyitler Kimyanayi AS's current Research & Development is ₺0.7 Mil. Overall, Seyitler Kimyanayi AS has a GF Score™ of 64/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Seyitler Kimyanayi AS's Research & Development compare to ISRG and BDX?
Seyitler Kimyanayi AS's Research & Development of ₺0.7 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Seyitler Kimyanayi AS and its competitors. Seyitler Kimyanayi AS's current Research & Development is ₺0.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Seyitler Kimyanayi AS stock overvalued right now?
Based on GuruFocus' analysis, Seyitler Kimyanayi AS (IST:SEYKM) is currently considered Significantly Overvalued. The stock's GF Value™ is ₺2.82, compared to a current price of ₺4.63 — trading 64.2% above its estimated fair value. The current Research & Development is ₺0.7 Mil. Seyitler Kimyanayi AS's overall GF Score™ is 64/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Seyitler Kimyanayi AS (IST:SEYKM), the current Research & Development is ₺0.7 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Seyitler Kimyanayi AS (IST:SEYKM) Overvalued in 2026?

Based on GuruFocus' analysis, Seyitler Kimyanayi AS stock appears to be overvalued. The current stock price of ₺4.63 is trading 64.2% above its estimated GF Value™ of ₺2.82. GuruFocus considers Seyitler Kimyanayi AS to be Significantly Overvalued.

Key valuation signals for IST:SEYKM:

  • Research & Development: ₺0.7 Mil
  • GF Value™: ₺2.82 vs. price of ₺4.63 (64.2% above fair value)
  • GF Score™: 64/100 with 6 warning signs

No single metric tells the full story. See the IST:SEYKM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Seyitler Kimyanayi AS Business Description

Address Ataturk Org. San. Bolgesi, 10007 Sok. Number 7, Cigli, Izmir, TUR, 35620
Seyitler Kimya Sanayi AS is engaged in manufacturing Medical plaster, first aid plaster, and capsicum perforated rheumatism plaster. Its products include Medical Tapes, Medical fluids, Wound Dressing, First-Aid plaster and Eye products among others.
64GF Score

Get the complete analysis for IST:SEYKM

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺4.63
Price
₺2.82
GF Value